185 related articles for article (PubMed ID: 11730166)
21. Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.
Muangthai K; Tankaew P; Varinrak T; Uthi R; Rojanasthien S; Sawada T; Sthitmatee N
J Vet Med Sci; 2018 Jan; 80(1):68-76. PubMed ID: 29109353
[TBL] [Abstract][Full Text] [Related]
22. Immunisation of cattle and buffaloes with live haemorrhagic septicaemia vaccine.
Carter GR; Myint A; Van Khar R; Khin A
Vet Rec; 1991 Aug; 129(9):203. PubMed ID: 1957476
[No Abstract] [Full Text] [Related]
23. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
[TBL] [Abstract][Full Text] [Related]
24. Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminants.
Maslog FS
Dev Biol Stand; 1998; 92():301-7. PubMed ID: 9554285
[TBL] [Abstract][Full Text] [Related]
25. Live haemorrhagic septicaemia vaccine for cattle and buffaloes.
Jones TO; Myint A; Carter GR
Vet Rec; 2002 Jan; 150(4):120. PubMed ID: 11838999
[No Abstract] [Full Text] [Related]
26. Binding of bovine transferrin by Pasteurella multocida serotype B:2,5, a strain which causes haemorrhagic septicaemia in buffalo and cattle.
Veken JW; Oudega B; Luirink J; de Graaf FK
FEMS Microbiol Lett; 1994 Jan; 115(2-3):253-7. PubMed ID: 8138137
[TBL] [Abstract][Full Text] [Related]
27. Recombinant transferrin binding protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model.
Shivachandra SB; Yogisharadhya R; Kumar A; Mohanty NN; Nagaleekar VK
Res Vet Sci; 2015 Feb; 98():1-6. PubMed ID: 25544697
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of an inactivated recombinant vaccine encoding a fimbrial protein of Pasteurella multocida B:2 against hemorrhagic septicemia in goats.
Mohd Yasin IS; Mohd Yusoff S; Mohd ZS; Abd Wahid Mohd E
Trop Anim Health Prod; 2011 Jan; 43(1):179-87. PubMed ID: 20697957
[TBL] [Abstract][Full Text] [Related]
29. Structural analysis and cross-protective efficacy of recombinant 87 kDa outer membrane protein (Omp87) of Pasteurella multocida serogroup B:2.
Kumar A; Yogisharadhya R; Ramakrishnan MA; Viswas KN; Shivachandra SB
Microb Pathog; 2013 Dec; 65():48-56. PubMed ID: 24120691
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of haemorrhagic septicaemia alum-precipitated vaccine.
Myint A; Jones TO
Vet Rec; 2007 Feb; 160(5):172. PubMed ID: 17277309
[No Abstract] [Full Text] [Related]
31. Haemorrhagic septicaemia vaccines.
Verma R; Jaiswal TN
Vaccine; 1998 Jul; 16(11-12):1184-92. PubMed ID: 9682378
[TBL] [Abstract][Full Text] [Related]
32. Specific antibodies of Pasteurella multocida in newborn calves of vaccinated dams.
el-Eragi AM; Mukhtar MM; Babiker SH
Trop Anim Health Prod; 2001 Jul; 33(4):275-83. PubMed ID: 11474861
[TBL] [Abstract][Full Text] [Related]
33. Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida ΔhyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves.
Crouch CF; LaFleur R; Ramage C; Reddick D; Murray J; Donachie W; Francis MJ
Vaccine; 2012 Mar; 30(13):2320-8. PubMed ID: 22306859
[TBL] [Abstract][Full Text] [Related]
34. Responses of pro-inflammatory cytokines, acute phase proteins and cytological analysis in serum and cerebrospinal fluid during haemorrhagic septicaemia infection in buffaloes.
Chung ELT; Jesse FFA; Marza AD; Ibrahim HH; Abba Y; Zamri-Saad M; Haron AW; Lila MAM; Saharee AA; Omar AR; Bakar MZA; Norsidin MJ
Trop Anim Health Prod; 2019 Jul; 51(6):1773-1782. PubMed ID: 30919320
[TBL] [Abstract][Full Text] [Related]
35. The ability of lipopolysaccharide (LPS) of Pasteurella multocida B:2 to induce clinical and pathological lesions in the nervous system of buffalo calves following experimental inoculation.
Marza AD; Jesse Abdullah FF; Ahmed IM; Teik Chung EL; Ibrahim HH; Zamri-Saad M; Omar AR; Abu Bakar MZ; Saharee AA; Haron AW; Alwan MJ; Mohd Lila MA
Microb Pathog; 2017 Mar; 104():340-347. PubMed ID: 28126667
[TBL] [Abstract][Full Text] [Related]
36. In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo.
Ghaffar A; Tariq A
Gene; 2016 Apr; 580(1):58-66. PubMed ID: 26779825
[TBL] [Abstract][Full Text] [Related]
37. Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.
Tabatabaei M; Liu Z; Finucane A; Parton R; Coote J
Infect Immun; 2002 Jul; 70(7):3355-62. PubMed ID: 12065473
[TBL] [Abstract][Full Text] [Related]
38. Effect of storage on the prevalent alum-precipitated hemorrhagic septicaemia vaccine in Pakistan and preparation of a more efficient oil adjuvant vaccine using dense culture of Pasteurella multocida Roberts type 1 on an improved culture medium.
Sheikh MA; Tasneem K; Zafar MS; Butt IA; Shakoori AR
Zentralbl Veterinarmed B; 1995 Mar; 42(1):28-34. PubMed ID: 7483898
[TBL] [Abstract][Full Text] [Related]
39. Generation of porcine Pasteurella multocida ghost vaccine and examination of its immunogenicity against virulent challenge in mice.
Ran X; Meng XZ; Geng HL; Chang C; Chen X; Wen X; Ni H
Microb Pathog; 2019 Jul; 132():208-214. PubMed ID: 30980881
[TBL] [Abstract][Full Text] [Related]
40. Development of a clinical syndrome resembling haemorrhagic septicaemia in the buffalo following intravenous inoculation of Pasteurella multocida serotype B:2 endotoxin and the role of tumour necrosis factor-alpha.
Horadagoda NU; Hodgson JC; Moon GM; Wijewardana TG; Eckersall PD
Res Vet Sci; 2002 Jun; 72(3):194-200. PubMed ID: 12076113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
